Back
Dianthus Therapeutics Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
1
DNTH
Dianthus Therapeutics
Last Price:
20.87
Seasonality Move:
12.89%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNTH is experiencing selling pressure, which indicates risk of future bearish movement.
Dianthus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.66 | Sell |
| 20-day SMA: | 26.9 | Sell |
| 50-day SMA: | 27.25 | Sell |
| 200-day SMA: | 26.2 | Sell |
| 8-day EMA: | 24.1 | Sell |
| 20-day EMA: | 26.01 | Sell |
| 50-day EMA: | 26.96 | Sell |
| 200-day EMA: | 24.96 | Sell |
Dianthus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.34 | Sell |
| Relative Strength Index (14 RSI): | 23.86 | Sell |
| Chaikin Money Flow: | -146216 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.88 - 29.38) | Sell |
| Bollinger Bands (100): | (26.17 - 29.09) | Sell |
Dianthus Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dianthus Therapeutics Stock
Is Dianthus Therapeutics Stock a Buy?
- Dianthus Therapeutics share price is 20.77 while DNTH 8-day simple moving average is 24.66, which is a Sell signal.
- The stock price of DNTH is 20.77 while Dianthus Therapeutics 20-day SMA is 26.90, which makes it a Sell.
- Dianthus Therapeutics 50-day simple moving average is 27.25 while DNTH share price is 20.77, making it a Sell technically.
- DNTH stock price is 20.77 and Dianthus Therapeutics 200-day simple moving average is 26.20, creating a Sell signal.
DNTH Technical Analysis vs Fundamental Analysis
Sell
1
Dianthus Therapeutics (DNTH)
is a Sell
Is Dianthus Therapeutics a Buy or a Sell?
-
Dianthus Therapeutics stock is rated a Sell
The current Dianthus Therapeutics [DNTH] share price is $20.77. The Score for DNTH is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Dianthus Therapeutics Stock Info
Market Cap:
614.73M
Price in USD:
20.77
Share Volume:
194.96K
Dianthus Therapeutics 52-Week Range
52-Week High:
33.77
52-Week Low:
6.58
Sell
1
Dianthus Therapeutics (DNTH)
is a Sell
Dianthus Therapeutics Share Price Forecast
-
What is the Dianthus Therapeutics stock price today?
The Dianthus Therapeutics stock price is 20.77 USD today. -
Will DNTH stock go up or go down?
Dianthus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Dianthus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dianthus Therapeutics is overvalued.
Is Dianthus Therapeutics Stock a Buy?
- Dianthus Therapeutics share price is 20.77 while DNTH 8-day exponential moving average is 24.10, which is a Sell signal.
- The stock price of DNTH is 20.77 while Dianthus Therapeutics 20-day EMA is 26.01, which makes it a Sell.
- Dianthus Therapeutics 50-day exponential moving average is 26.96 while DNTH share price is 20.77, making it a Sell technically.
- DNTH stock price is 20.77 and Dianthus Therapeutics 200-day simple moving average is 24.96, creating a Sell signal.
Technical Analysis of Dianthus Therapeutics
Should I short Dianthus Therapeutics stock?
- DNTH Moving Average Covergence Divergence (MACD) indicator is -1.34, suggesting Dianthus Therapeutics is a Sell
- Dianthus Therapeutics Relative Strength Index (RSI) is 23.86, which suggest Dianthus Therapeutics is oversold
- The Bollinger Bands (25) for Dianthus Therapeutics is (24.88 - 29.38), which suggest Dianthus Therapeutics is a Sell
- The Bollinger Bands (100) for Dianthus Therapeutics is (26.17 - 29.09), which suggest Dianthus Therapeutics is a Sell
* Dianthus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.